ABBV - AbbVie Inc.

NYSE - NYSE Delayed Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201712/31/201612/31/201512/31/2014
Net Income5,309,0005,953,0005,144,0001,774,000
Operating Activities, Cash Flows Provided By or Used In
Depreciation1,501,0001,189,000836,000786,000
Adjustments To Net Income3,141,0001,588,0001,051,0001,777,000
Changes In Accounts Receivables-391,000-71,000-1,076,000-172,000
Changes In Liabilities425,000-1,187,0001,503,000-193,000
Changes In Inventories93,000-38,000-434,000-203,000
Changes In Other Operating Activities-118,000-393,000511,000-220,000
Total Cash Flow From Operating Activities9,960,0007,041,0007,535,0003,549,000
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures-529,000-479,000-532,000-612,000
Investments563,000-2,956,00048,000308,000
Other Cash flows from Investing Activities-118,000118,000118,000
Total Cash Flows From Investing Activities-274,000-6,074,000-12,936,000-926,000
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid-4,107,000-3,717,000-3,294,000-2,661,000
Sale Purchase of Stock----
Net Borrowings-3,0005,588,00016,623,000-5,000
Other Cash Flows from Financing Activities-246,000-34,000-146,000-194,000
Total Cash Flows From Financing Activities-5,512,000-3,928,0005,752,000-3,293,000
Effect Of Exchange Rate Changes29,000-338,000-300,000-577,000
Change In Cash and Cash Equivalents4,203,000-3,299,00051,000-1,247,000